19.06.2019 • News

Christian Kohlpaintner to Leave Clariant

Christian Kohlpaintner, member of Clariant’s executive committee, decided to...
Christian Kohlpaintner, member of Clariant’s executive committee, decided to resign from his position effective June 30, 2019. Source: Clariant

Swiss specialty chemical company Clariant announced that Christian Kohlpaintner, who is a member of the company’s executive committee, decided to resign from his position effective June 30, 2019.

Kohlpaintner led the business units Care Chemicals, Catalysis and Natural Resources and was accountable for the regions Greater China, India, Japan, and South East Asia & Pacific. In addition, he was responsible for Group Technology & Innovation and Corporate Sustainability & Regulatory Affairs.

“We very much regret the decision of Christian Kohlpaintner to leave Clariant”, said Hariolf Kottmann, chairman of Clariant’s board of directors. “He made significant contributions to shaping the company into the leading specialty chemicals player it is today. From business turnarounds and acquisitions to innovations, he has created substantial value for Clariant over the past 10 years. It is largely thanks to him that Clariant is inextricably linked to topics such as sustainability, innovation and our China growth strategy. We wish him all the best for his future endeavors.”

For the time being, Kohlpaintner’s responsibilities will be assumed by the remaining members of the executive committee, the company said.

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.